curam
sandoz new zealand limited - amoxicillin trihydrate 287mg equivalent to amoxycillin 250 mg; ; potassium clavulanate 149mg equivalent to clavulanic acid 125 mg - film coated tablet - 250mg/125mg - active: amoxicillin trihydrate 287mg equivalent to amoxycillin 250 mg potassium clavulanate 149mg equivalent to clavulanic acid 125 mg excipient: croscarmellose sodium ethylcellulose hypromellose magnesium stearate microcrystalline cellulose povidone purified talc purified water titanium dioxide triethyl citrate - short term treatment of common bacterial infections such as: upper respiratory tract infections (including ent): e.g. tonsillitis, sinusitis, otitis media lower respiratory tract infections: e.g. acute exacerbations of chronic bronchitis, lobar and broncho-pneumonia genito-urinary tract infections: e.g. cystitis, urethritis, pyelonephritis, female genital infections skin and soft tissue infections bone and joint infections: e.g. osteomyelitis other infections: e.g. septic abortion, puerperal sepsis, intra-abdominal sepsis, septicaemia, peritonitis and post-surgical infections. prophylaxis against infection which may be associated with major surgical procedures such as gastro-intestinal, pelvic, head and neck, cardiac, renal, joint replacement and biliary tract surgery. infections caused by amoxycillin susceptible organisms are amenable to amoxycillin/clavulanic acid treatment due to its amoxycillin content. mixed infections caused by amoxycillin susceptible organisms in conjunction with amoxycillin/clavulanic acid susceptible beta-lactamase-producing organisms may therefore be treated by amoxycillin/clavulanic acid.
amoxycillin/clavulanic acid actavis 875/125 amoxicillin 875 mg (as trihydrate) and clavulanic acid 125 mg (as potassium clavulan
medis pharma pty ltd - amoxicillin trihydrate,potassium clavulanate -
ratio-aclavulanate tablet
ratiopharm inc division of teva canada limited - amoxicillin (amoxicillin trihydrate); clavulanic acid (potassium clavulanate) - tablet - 250mg; 125mg - amoxicillin (amoxicillin trihydrate) 250mg; clavulanic acid (potassium clavulanate) 125mg - aminopenicillins
curam duo 500/125 amoxicillin 500mg (as trihydrate) & clavulanic acid 125mg (as potassium) tablet strip pack
sandoz pty ltd - amoxicillin trihydrate, quantity: 574 mg (equivalent: amoxicillin, qty 500 mg); potassium clavulanate, quantity: 149 mg (equivalent: clavulanic acid, qty 125 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; purified talc; povidone; triethyl citrate; hypromellose; titanium dioxide; ethylcellulose; cetyl alcohol; sodium lauryl sulfate - short-term treatment of bacterial infection at the following sites when caused by amoxycillin/clavulanic acid sensitive, beta-lactamase producing organisms. skin and skin structure infections. urinary tract infections (uncomplicated and complicated). upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis. lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis. appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to curam tablets. however, when there is reason to believe an infection may involve any of the beta-lactamase producing organisms listed in the microbiological section, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to curam tablets should not require the addition of another antibiotic due to the amoxycillin content of curam tablets.
augmentin duo amoxicillin 500mg (as trihydrate) & clavulanic acid 125mg (as potassium clavulanate)
aspen pharmacare australia pty ltd - amoxicillin, quantity: 500 mg; clavulanic acid, quantity: 125 mg - tablet, film coated - excipient ingredients: colloidal anhydrous silica; sodium starch glycollate; microcrystalline cellulose; magnesium stearate; titanium dioxide; hypromellose; propylene glycol; purified talc; ethylcellulose - augmentin tablets are indicated for short term treatment of bacterial infections at the following sites when caused by sensitive organisms (refer to microbiology): urinary tract infections (uncomplicated and complicated); lower respiratory tract infections, including community acquired pneumonia and acute exacerbations of chronic bronchitis; upper respiratory tract infections, such as sinusitis, otitis media and recurrent tonsillitis; skin and skin structure infections. appropriate culture and susceptibility studies should be performed to identify the causative organisms(s) and its (their) susceptibility to augmentin tablets. however, when there is reason to believe an infection may involve any of the b-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptibility studies. once these results are known, therapy should be adjusted if appropriate. the treatment of mixed infections caused by amoxycillin susceptible organisms and b-lactamase producing organisms susceptible to augmentin tablets should not require the addition of another antibiotic due to the amoxycillin content of these products.
synulox ready to use injection
zoetis belgium s.a. - amoxicillin trihydrate; potassium clavulanate - suspension for injection - 140,35 milligram(s)/millilitre - amoxicillin and enzyme inhibitor - cats, cattle, dogs, pigs - antibacterial
synulox ready to use injection
zoetis belgium s.a. - amoxicillin trihydrate; potassium clavulanate - suspension for injection - 140, 35 milligram(s)/millilitre - amoxicillin and enzyme inhibitor - cats, cattle, dogs, pigs - antibacterial
cladaxxa 200 mg/50 mg chewable tablets for cats and dogs
krka, d.d., novo mesto - amoxicillin trihydrate; potassium clavulanate - chewable tablet - 200,50 mg/tablet - amoxicillin and enzyme inhibitor
cladaxxa 40 mg/10 mg chewable tablets for cats and dogs
krka, d.d., novo mesto - amoxicillin trihydrate; potassium clavulanate - chewable tablet - 40,10 mg/tablet - amoxicillin and enzyme inhibitor
cladaxxa 400 mg/100 mg chewable tablets for dogs
krka, d.d., novo mesto - amoxicillin trihydrate; potassium clavulanate - chewable tablet - 400,100 mg/tablet - amoxicillin and enzyme inhibitor